miR-222-3p can also trigger malignant transformation by altering the expression levels of genes involved in cell death and survival, such as CAV2, PTEN, FOXO3, CDK6 and promote aggressive ER-negative breast tumors by increasing proliferation and migratory activity of breast cancer cells [40, 41]. This evidence concerns the gene PTEN and breast carcinoma.